Back to Search
LINDA BOSSERMAN, M.D., F.A.C.P
M.D., F.A.C.P
Medical Oncology Physician
NPI: 1346289824IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
G49004(CA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
G49004(CA)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
STANFORD UNIVERSITY SCHOOL OF MEDICINE
Class of 1981
Research & Publications (10)
Denosumab treatment of prostate cancer with bone metastases and increased urine N-telopeptide levels after therapy with intravenous bisphosphonates: results of a randomized phase II trial.
PMID 19524963·J Urol·2009
3-trial
Zoledronic acid effectively prevents aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST study 36-month follow-up results.
PMID 19433387·Clin Breast Cancer·2009
4-observational
A phase I/II trial of trastuzumab plus erlotinib in metastatic HER2-positive breast cancer: a dual ErbB targeted approach.
PMID 19299235·Clin Breast Cancer·2009
3-trial
Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
PMID 18021478·Clin Breast Cancer·2007
8-other
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.
PMID 17606974·J Clin Oncol·2007
3-trial
Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial.
PMID 16710026·J Clin Oncol·2006
3-trial
If at first you don't succeed, don't quit, try again: The Centers For Medicare and Medicaid Services demonstration project on quality of care--2005 and 2006.
PMID 16553141·J Support Oncol·2006
8-other
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma.
PMID 14584068·Cancer·2003
3-trial
Fourteen-day CHOP supported with granulocyte colony-stimulating factor in patients with aggressive non-Hodgkin's lymphoma: results of a phase II study.
PMID 14556680·Clin Lymphoma·2003
3-trial
Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.
PMID 11707827·Clin Lymphoma·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1500 DUARTE RD
DUARTE, CA 91010 - Phone
- (626) 256-4673
Quick Facts
- NPI
- 1346289824
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 45
- Publications
- 10
Are you this provider?
Claim Your Profile